Isolated Peptide from Spider Venom Modulates Dendritic Cells In Vitro: A Possible Application in Oncoimmunotherapy for Glioblastoma.
Phoneutria nigriventer
PnV
cell therapy
dendritic cells vaccine
glioblastoma
immunoadjuvant
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
27 03 2023
27 03 2023
Historique:
received:
18
08
2022
revised:
04
01
2023
accepted:
05
01
2023
medline:
14
4
2023
entrez:
13
4
2023
pubmed:
14
4
2023
Statut:
epublish
Résumé
Dendritic cells (DCs) vaccine is a potential tool for oncoimmunotherapy. However, it is known that this therapeutic strategy has failed in solid tumors, making the development of immunoadjuvants highly relevant. Recently, we demonstrated that
Identifiants
pubmed: 37048096
pii: cells12071023
doi: 10.3390/cells12071023
pmc: PMC10092987
pii:
doi:
Substances chimiques
Spider Venoms
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Nat Rev Drug Discov. 2019 May;18(5):339-357
pubmed: 30728472
Trends Cancer. 2017 Sep;3(9):611-614
pubmed: 28867164
Nature. 1998 Mar 19;392(6673):245-52
pubmed: 9521319
J Cell Physiol. 2019 Feb;234(2):1398-1415
pubmed: 30078202
Microsc Res Tech. 2009 Apr;72(4):310-6
pubmed: 19009596
Immunol Rev. 2016 Jul;272(1):52-64
pubmed: 27319342
Sci Rep. 2020 Apr 3;10(1):5876
pubmed: 32246025
Vaccine. 2018 May 31;36(23):3247-3253
pubmed: 29724512
Cancer Cell Int. 2005 May 10;5(1):13
pubmed: 15885136
J Immunol. 2017 Mar 15;198(6):2223-2231
pubmed: 28264998
Front Immunol. 2014 Apr 01;5:131
pubmed: 24744755
Nature. 2007 Sep 27;449(7161):419-26
pubmed: 17898760
Front Immunol. 2013 Apr 03;4:82
pubmed: 23565116
Cell Mol Neurobiol. 2005 Aug;25(5):929-41
pubmed: 16133944
Invest Ophthalmol Vis Sci. 2015 Nov;56(12):7179-85
pubmed: 26540656
BMC Cancer. 2008 Oct 08;8:291
pubmed: 18840301
Lancet Oncol. 2004 Nov;5(11):681-9
pubmed: 15522656
PLoS One. 2016 Jan 21;11(1):e0146622
pubmed: 26795765
Mol Cells. 2016 Oct;39(10):734-741
pubmed: 27788572
J Biochem. 2021 Sep 22;170(1):51-68
pubmed: 33599263
Cancer Biol Ther. 2005 May;4(5):501-5
pubmed: 15917653
Oncol Lett. 2021 Feb;21(2):90
pubmed: 33376523
Immunity. 2013 Jul 25;39(1):38-48
pubmed: 23890062
J Clin Transl Res. 2017 May 24;3(2):233-249
pubmed: 30873475
Cancer Cell Int. 2020 Dec 17;20(1):576
pubmed: 33327966
J Transl Med. 2018 May 29;16(1):142
pubmed: 29843811
Annu Rev Immunol. 2015;33:563-606
pubmed: 25665078
Curr Opin Immunol. 2003 Apr;15(2):138-47
pubmed: 12633662
Nat Rev Cancer. 2004 Jan;4(1):11-22
pubmed: 14708024
Ann Oncol. 2018 May 1;29(5):1312-1319
pubmed: 29554212
Lancet. 2001 Feb 17;357(9255):539-45
pubmed: 11229684
Melanoma Res. 2003 Oct;13(5):521-30
pubmed: 14512794
Transl Oncol. 2018 Jun;11(3):686-690
pubmed: 29627706
Hum Vaccin Immunother. 2014;10(11):3332-46
pubmed: 25483639
J Transl Med. 2006 Aug 16;4:36
pubmed: 16914047
Clin Dev Immunol. 2011;2011:267539
pubmed: 21922022
Vaccine. 2005 Mar 18;23(17-18):2367-73
pubmed: 15755630
Mediators Inflamm. 2012;2012:690643
pubmed: 22851815
Acta Pharm Sin B. 2021 May;11(5):1129-1147
pubmed: 34094824